Skip to main content
. 2024 Oct 9;10(21):e38806. doi: 10.1016/j.heliyon.2024.e38806

Table 4.

Perioperative variables in different subgroups by R.E.N.A.L. score.

R.E.N.A.L. score <8 R.E.N.A.L. score ≥8
No 3D 3D P value No 3D 3D P value
No. of patients 88 91 89 56
Ischaemia timec (min) 19.4, 19.0 (15.0; 22.5) 19.6, 20.0 (15.0; 22.0) 0.783 24.7, 23.5 (20.0; 29.5) 26.4, 26.0 (20.0; 28.5) 0.256
EBLc (ml) 79.6, 50.0 (50.0; 100.0) 49.5, 50.0 (20.0; 50.0) 0.002 147.9, 50 (50; 100) 75.9, 50 (50; 100) 0.046
Operative timec (min) 131.6, 122.5 (100.0; 155.0) 118.5, 117.0 (95.0; 135.0) 0.027 156.0, 145.0 (110.0; 182.5) 145.7, 132.5 (120.0; 166.0) 0.521
Use of intraoperative USa 8 (9.1) 2 (2.2) 0.093 21 (23.6) 9 (16.1) 0.191
Intraoperative complicationsa 1 (1.1) 0 (0) 0.492 7 (7.9) 0 (0) 0.030
Transfusionsa 1 (1.1) 0 (0) 0.492 7 (7.9) 0 (0) 0.030
Conversion to radical nephrectomya 1 (1.1) 0 (0) 0.492 1 (1.1) 0 (0) 0.618
Postoperative complications, Claviena 0.092 <0.001
1 8 (9.1) 3 (3.3) 19 (21.3) 2 (3.6)
≥2 4 (4.5) 1 (1.1) 12 (13.5) 1 (1.8)
Preoperative stage of renal insufficiencya 0.147 0.488
1 76 (86.4)76 (86.4) 86 (94.5) 78 (87.6) 49 (87.5)
2 11 (12.5) 4 (4.4) 9 (10.1) 7 (12.5)
3 1 (1.1) 1 (1.1) 2 (2.2) 0 (0.0)
Postoperative stage of renal insufficiencya 0.085 0.728
1 72 (81.8) 83 (91.2) 71 (79.8) 45 (80.4)
2 15 (17.0) 6 (6.6) 17 (19.1) 11 (19.6)
3 1 (1.1) 2 (2.2) 1 (1.1) 0 (0.0)
ΔSCrc (μmol/L) 0.2, 0.3 (−5.8; 5.8) 1.4, 1.9 (−3.6; 5.9) 0.321 6.0, 3.6 (−2.0; 3.5) 5.2, 5.1 (−3.1; 11.3) 0.845
Length of stayc (day) 10.1, 10 (8; 11) 10.2, 10 (8; 11) 0.944 11.7, 11 (9; 14) 10.5, 10 (8; 12) 0.027

EBL = estimated blood loss; SCr = serum creatine; US = ultrasonography; a = no. (%); c = mean, median (interquartile range).